|
Non-susceptibilities of Streptococcus pneumoniae (SPN) in U.S. communities, 1997–2002 |
||||||||
| Unit: % |
||||||||
|
|
||||||||
| Antibiotic |
1997 |
1998 |
1999 |
2000 |
2001 |
2002 |
Average Resistance |
Average Growth Rate |
|
|
||||||||
| Penicillin |
25 |
24 |
27 |
28 |
26 |
21 |
25 |
2 |
| Cefotaxime |
13 |
14 |
17 |
18 |
16 |
12 |
15 |
-1 |
| Erythromycin |
15 |
15 |
21 |
22 |
19 |
17 |
18 |
4 |
| TMP/Sulfa |
29 |
29 |
32 |
32 |
30 |
25 |
30 |
-3 |
| Levofloxacin |
n/a |
0.2 |
0.2 |
0.3 |
0.7 |
0.5 |
0.4 |
39 |
| Vancomycin |
0 |
0 |
0 |
0 |
0 |
0 |
18 |
8 |
Zhang et al. Globalization and Health 2006 2:6 doi:10.1186/1744-8603-2-6 |
||||||||